# Inhibrx Biosciences Inc. (INBX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/INBX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -70.09M | $ -67.92M | N/A | $ -52.98M |
| 2025 | $ 1.33M | $ -143.40M | $ -132.93M | $ 107.01M | $ 7.99M |
| 2024 | $ 210.2K | $ 1.77B | $ -207.07M | $ 8.05M | $ 133.58M |
| 2023 | $ 1.95M | $ -260.73M | $ -199.92M | $ 210.14M | $ 43.50M |
| 2022 | $ 2.43M | $ -168.18M | $ -129.57M | $ 207.10M | $ 58.06M |
| 2021 | $ 8.54M | $ -97.19M | $ -96.50M | $ 72.14M | $ 52.38M |
| 2020 | $ 16.32M | $ -96.98M | $ -62.85M | $ 37.45M | $ 75.47M |
| 2019 | $ 11.74M | $ -66.34M | $ -43.74M | $ 41.73M | $ -93.57M |
| 2018 | $ 9.60M | $ -27.63M | $ -30.68M | $ 9.49M | $ -57.64M |
| 2017 | $ 378.5K | $ -10.64M | $ -9.75M | $ 14.66M | $ -28.77M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Liabilities / Eq | -3.91 |
| Current Ratio | 5.07 |

## Other views

- [Metrics](https://sponda.capital/en/INBX.md)
- [Charts](https://sponda.capital/en/INBX/charts.md)
- [Compare](https://sponda.capital/en/INBX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.